BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12648785)

  • 1. Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver.
    Wulf J; Hädinger U; Oppitz U; Thiele W; Flentje M
    Radiother Oncol; 2003 Feb; 66(2):141-50. PubMed ID: 12648785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.
    Admiraal MA; Schuring D; Hurkmans CW
    Radiother Oncol; 2008 Jan; 86(1):55-60. PubMed ID: 18082905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic radiotherapy of targets in the lung and liver.
    Wulf J; Hädinger U; Oppitz U; Thiele W; Ness-Dourdoumas R; Flentje M
    Strahlenther Onkol; 2001 Dec; 177(12):645-55. PubMed ID: 11789403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of target coverage and margins adequacy during CyberKnife Lung Optimized Treatment.
    Ricotti R; Seregni M; Ciardo D; Vigorito S; Rondi E; Piperno G; Ferrari A; Zerella MA; Arculeo S; Francia CM; Sibio D; Cattani F; De Marinis F; Spaggiari L; Orecchia R; Riboldi M; Baroni G; Jereczek-Fossa BA
    Med Phys; 2018 Apr; 45(4):1360-1368. PubMed ID: 29431863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
    Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
    Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma.
    Chau RM; Teo PM; Choi PH; Cheung KY; Lee WY
    Radiother Oncol; 2001 Feb; 58(2):143-53. PubMed ID: 11166865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame.
    Wulf J; Hädinger U; Oppitz U; Olshausen B; Flentje M
    Radiother Oncol; 2000 Nov; 57(2):225-36. PubMed ID: 11054527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracranial stereotactic radiotherapy: evaluation of PTV coverage and dose conformity.
    Hädinger U; Thiele W; Wulf J
    Z Med Phys; 2002; 12(4):221-9. PubMed ID: 12575435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulated real-time dose reconstruction for moving tumors in stereotactic liver radiotherapy.
    Skouboe S; Poulsen PR; Muurholm CG; Worm E; Hansen R; Høyer M; Ravkilde T
    Med Phys; 2019 Nov; 46(11):4738-4748. PubMed ID: 31468543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability.
    Stroom JC; de Boer HC; Huizenga H; Visser AG
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):905-19. PubMed ID: 10098447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
    Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
    Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Internal target volume definition using four-dimensional CT and dosimetric evaluation for hepatocellular carcinoma].
    Xi M; Liu MZ; Deng XW; Liu H; Huang XY; Zhang L; Li QQ; Hu YH; Cai L; Cui NJ
    Ai Zheng; 2007 Jan; 26(1):1-8. PubMed ID: 17222359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionated stereotactic radiotherapy boost for gynecologic tumors: an alternative to brachytherapy?
    Mollà M; Escude L; Nouet P; Popowski Y; Hidalgo A; Rouzaud M; Linero D; Miralbell R
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):118-24. PubMed ID: 15850911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Customized computed tomography-based boost volumes in breast-conserving therapy: use of three-dimensional histologic information for clinical target volume margins.
    Hanbeukers B; Borger J; van den Ende P; van der Ent F; Houben R; Jager J; Keymeulen K; Murrer L; Sastrowijoto S; van de Vijver K; Boersma L
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):757-63. PubMed ID: 19304402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotoxic dose escalation in the treatment of lung cancer by means of heterogeneous dose distributions in the presence of respiratory motion.
    Baker M; Nielsen M; Hansen O; Jahn JW; Korreman S; Brink C
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):849-55. PubMed ID: 21570211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of simple IMRT delivery techniques for non-small cell lung cancer patients with respiratory motion using 4DCT.
    Reitz B; Parda DS; Colonias A; Lee V; Miften M
    Med Dosim; 2009; 34(2):158-69. PubMed ID: 19410146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repositioning accuracy of a commercially available double-vacuum whole body immobilization system for stereotactic body radiation therapy.
    Fuss M; Salter BJ; Rassiah P; Cheek D; Cavanaugh SX; Herman TS
    Technol Cancer Res Treat; 2004 Feb; 3(1):59-67. PubMed ID: 14750894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer.
    Siedschlag C; Boersma L; van Loon J; Rossi M; van Baardwijk A; Gilhuijs K; Stroom J
    Radiother Oncol; 2011 Sep; 100(3):344-50. PubMed ID: 21955665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.
    Vicini F; Winter K; Straube W; Wong J; Pass H; Rabinovitch R; Chafe S; Arthur D; Petersen I; McCormick B
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1531-7. PubMed ID: 16198508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.